Development and efficacy of feed-based recombinant vaccine encoding the cell wall surface anchor family protein of Streptococcus agalactiae against streptococcosis in Oreochromis sp.

This study was carried out to determine the antibody responses and protective capacity of an inactivated recombinant vaccine expressing the cell wall surface anchor family protein of Streptococcus agalactiae following oral vaccination against streptococcosis in tilapia. Tilapia were vaccinated orall...

Full description

Saved in:
Bibliographic Details
Main Authors: M., Nur Nazifah, Mohd Yusoff, Md Sabri, A., Siti Zahrah
Format: Article
Language:English
Published: Elsevier 2014
Online Access:http://psasir.upm.edu.my/id/eprint/37049/1/Development%20and%20efficacy%20of%20feed.pdf
http://psasir.upm.edu.my/id/eprint/37049/
Tags: Add Tag
No Tags, Be the first to tag this record!
id my.upm.eprints.37049
record_format eprints
spelling my.upm.eprints.370492015-10-06T03:54:47Z http://psasir.upm.edu.my/id/eprint/37049/ Development and efficacy of feed-based recombinant vaccine encoding the cell wall surface anchor family protein of Streptococcus agalactiae against streptococcosis in Oreochromis sp. M., Nur Nazifah Mohd Yusoff, Md Sabri A., Siti Zahrah This study was carried out to determine the antibody responses and protective capacity of an inactivated recombinant vaccine expressing the cell wall surface anchor family protein of Streptococcus agalactiae following oral vaccination against streptococcosis in tilapia. Tilapia were vaccinated orally with 106 CFU/mL of the recombinant vaccine incorporated in feed (feed-based recombinant vaccine) (vaccinated group or Group 1), 106 CFU/mL of pET-32 Ek/LIC vector without cell wall surface anchor family protein (control group or Group 2), 106 CFU/mL of formalin-killed cells of S. agalactiae vaccine incorporated in feed was also prepared (feed-based vaccine) (vaccinated group or Group 3), and unvaccinated control group or Group 4 (fed with commercial pellets). During the course of study, serum, mucus and gut lavage fluid were collected to evaluate the antibody levels via enzyme-linked immunosorbent assay (ELISA). The results showed that tilapia immunized with the feed-based recombinant vaccine developed a strong and significantly (P < 0.05) higher IgM antibody response in serum, mucus and gut lavage fluid samples compared to groups 2, 3 and 4. Following heat intervenes and intraperitoneal challenge, the rate of survivors (RPS) was 70% for the vaccinated group, and 0% for the rest of the groups. Therefore, the study revealed that the feed-based recombinant vaccine significantly provides high protection against high dose challenge in heat stress environment and enhances the production of the mucosal and humoral immunity. Elsevier 2014-03 Article PeerReviewed application/pdf en http://psasir.upm.edu.my/id/eprint/37049/1/Development%20and%20efficacy%20of%20feed.pdf M., Nur Nazifah and Mohd Yusoff, Md Sabri and A., Siti Zahrah (2014) Development and efficacy of feed-based recombinant vaccine encoding the cell wall surface anchor family protein of Streptococcus agalactiae against streptococcosis in Oreochromis sp. Fish & Shellfish Immunology, 37 (1). pp. 193-200. ISSN 1050-4648; ESSN: 1095-9947 10.1016/j.fsi.2014.01.011
institution Universiti Putra Malaysia
building UPM Library
collection Institutional Repository
continent Asia
country Malaysia
content_provider Universiti Putra Malaysia
content_source UPM Institutional Repository
url_provider http://psasir.upm.edu.my/
language English
description This study was carried out to determine the antibody responses and protective capacity of an inactivated recombinant vaccine expressing the cell wall surface anchor family protein of Streptococcus agalactiae following oral vaccination against streptococcosis in tilapia. Tilapia were vaccinated orally with 106 CFU/mL of the recombinant vaccine incorporated in feed (feed-based recombinant vaccine) (vaccinated group or Group 1), 106 CFU/mL of pET-32 Ek/LIC vector without cell wall surface anchor family protein (control group or Group 2), 106 CFU/mL of formalin-killed cells of S. agalactiae vaccine incorporated in feed was also prepared (feed-based vaccine) (vaccinated group or Group 3), and unvaccinated control group or Group 4 (fed with commercial pellets). During the course of study, serum, mucus and gut lavage fluid were collected to evaluate the antibody levels via enzyme-linked immunosorbent assay (ELISA). The results showed that tilapia immunized with the feed-based recombinant vaccine developed a strong and significantly (P < 0.05) higher IgM antibody response in serum, mucus and gut lavage fluid samples compared to groups 2, 3 and 4. Following heat intervenes and intraperitoneal challenge, the rate of survivors (RPS) was 70% for the vaccinated group, and 0% for the rest of the groups. Therefore, the study revealed that the feed-based recombinant vaccine significantly provides high protection against high dose challenge in heat stress environment and enhances the production of the mucosal and humoral immunity.
format Article
author M., Nur Nazifah
Mohd Yusoff, Md Sabri
A., Siti Zahrah
spellingShingle M., Nur Nazifah
Mohd Yusoff, Md Sabri
A., Siti Zahrah
Development and efficacy of feed-based recombinant vaccine encoding the cell wall surface anchor family protein of Streptococcus agalactiae against streptococcosis in Oreochromis sp.
author_facet M., Nur Nazifah
Mohd Yusoff, Md Sabri
A., Siti Zahrah
author_sort M., Nur Nazifah
title Development and efficacy of feed-based recombinant vaccine encoding the cell wall surface anchor family protein of Streptococcus agalactiae against streptococcosis in Oreochromis sp.
title_short Development and efficacy of feed-based recombinant vaccine encoding the cell wall surface anchor family protein of Streptococcus agalactiae against streptococcosis in Oreochromis sp.
title_full Development and efficacy of feed-based recombinant vaccine encoding the cell wall surface anchor family protein of Streptococcus agalactiae against streptococcosis in Oreochromis sp.
title_fullStr Development and efficacy of feed-based recombinant vaccine encoding the cell wall surface anchor family protein of Streptococcus agalactiae against streptococcosis in Oreochromis sp.
title_full_unstemmed Development and efficacy of feed-based recombinant vaccine encoding the cell wall surface anchor family protein of Streptococcus agalactiae against streptococcosis in Oreochromis sp.
title_sort development and efficacy of feed-based recombinant vaccine encoding the cell wall surface anchor family protein of streptococcus agalactiae against streptococcosis in oreochromis sp.
publisher Elsevier
publishDate 2014
url http://psasir.upm.edu.my/id/eprint/37049/1/Development%20and%20efficacy%20of%20feed.pdf
http://psasir.upm.edu.my/id/eprint/37049/
_version_ 1643831899271987200
score 13.211869